Ulcerative colitis exacerbating after placement of intragastric balloon for the treatment of obesity
โ Scribed by Francesco Manguso; Salvatore Picascia; Antonio Balzano
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 53 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
infliximab. In contrast, similar psoriasiform lesions are reported to have been induced by infliximab in a few patients with inflammatory bowel diseases. [3][4][5][6][7] Such an undesired, dermatologically adverse effect is considered a delayed hypersensitivity reaction that commonly occurs during v
Background: Increased activity of intestinal alkaline phosphatase (AP) occurs locally in patients with ulcerative colitis (UC), aimed at repairing inflammatory tissue damage. We evaluated the safety and preliminary efficacy of exogenous AP administered to patients with UC in an open-label, first-in-
## Background: The goal was to cross-sectionally assess fecal calprotectin after restorative proctocolectomy for pediatric-onset ulcerative colitis (uc). ## Methods: Fecal calprotectin, histology of the distal ileum, inflammation biochemistry, episodes of pouchitis, and bowel function were cross-
## Abstract **Background**: Leukocytapheresis (LCAP) is used as an adjunct therapy for patients with active ulcerative colitis (UC). Although, LCAP is routinely performed at 3,000 mL per session, we were interested to see that if this can be replaced with bodyweight (BW) adjusted volume. **Methods*